Esa Medika Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Esa Medika Mandiri Tbk. trades at Rp348 (market cap 623.94B, 1.87M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Esa Medika Mandiri Tbk. is far larger — about 3.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Esa Medika Mandiri Tbk. is more actively traded (1.87M versus 43.9K). Which is the better fit depends on your goals.
| EMMI | OBAT | |
|---|---|---|
Market Cap | 623.94B | 164.65B |
Volume | 1.87M | 43.9K |
Lot | 18.67K | 439 |
Turnover | 653.47M | 10.6M |
Average Price | 349.97 | 241.43 |
Value | 653.47M | 10.6M |
Indicative Equilibrium Price | 360 | 238 |
Indicative Equilibrium Volume | 841 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Read more on EMMI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →